Validation of the diagnosis of venous thromboembolism in general practice database studies

British Journal of Clinical Pharmacology

Volumn 49, Issue 6, 2000, Pages 591-596

  Lawrenson, R ^a   Todd, J C ^a   Leydon, G M ^b   Williams, T J ^c   Farmer, R D T ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c NONE

Author keywords

Database studies; Oral contraceptives; Validity; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ORAL CONTRACEPTIVE AGENT;

ARTICLE; DATA BASE; DEEP VEIN THROMBOSIS; GENERAL PRACTICE; HOSPITAL ADMISSION; HUMAN; LUNG EMBOLISM; PRIORITY JOURNAL; QUESTIONNAIRE; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, COMBINED; DATABASES, FACTUAL; EPIDEMIOLOGIC STUDIES; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; PREGNANCY; QUESTIONNAIRES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; THROMBOEMBOLISM;

EID: 0034073318     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00199.x     Document Type: Article

References (13)

1. 1 Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestogen components. Lancet 1995; 346: 1589-1593.
2. 2 Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. Br Med J 1996; 312: 83-88.
3. 3 World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case control study. Lancet 1995; 346: 1575-1582.
4. 4 Committee on the Safety of Medicines. Combined oral contraceptives and thromboembolism. London. Committee on the Safety of Medicines., 1995.
5. 5 Office for National Statistics. Legal Abortions June Quarter 1996 ONS, monitor AB. 97/1. London. Office for National Statistics., 1997.
6. 6 Farmer RDT, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR. Population based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet 1997; 349: 83-88.
7. 7 Poulter NR, Chang CL, Marmot M, Farley TM, Meirik O. Third-generation oral contraceptives and venous thrombosis [letter; comment]. Lancet 1997; 349: 732.
8. 8 Jick H, Jick SS, Myers MW, Vasilakis C. Third-generation oral contraceptives and venous thrombosis [letter; comment]. Lancet 1997; 349: 731-732.
9. 9 Vandenbroucke JP, Helmerhorst FM, Bloemenkamp KW, Rosendaal FR. Third-generation oral contraceptives and venous thrombosis [letter; comment]. Lancet 1997; 349: 731.
10. 10 Farmer RDT, Lawrenson RA, Todd J-C, et al. A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives. Br J Clin Pharmacol.
11. 11 Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J 1991; 302: 766-768.
12. 12 Van Staa T, Abenhaim L. The quality of information on a UK Database of Primary Care records: a study of hospitalizations due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Safety 1994; 3: 15-21.
13. 13 Evans JMM, MacDonald TMM. Misclassification and selection bias in case-control studies using an automated database. Pharmacoepidemiol Drug Safety 1997; 6: 313-318.